The antitumor effects of vitamin D in CRC are achieved through various pathways such as promoting cell cycle arrest in the G1 phase, reducing the synthesis of vascular endothelial growth factor (VEGF), and decreasing the ability of cell migration and angiogenesis. The gene discussed is VEGFA; the disease is colorectal carcinoma.